Literature DB >> 22308306

Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a.

Sandip M Kanse1, Andrea Gallenmueller, Sacha Zeerleder, Femke Stephan, Olivier Rannou, Stephanie Denk, Michael Etscheid, Guenter Lochnit, Marcus Krueger, Markus Huber-Lang.   

Abstract

Severe tissue injury results in early activation of serine protease systems including the coagulation and complement cascade. In this context, little is known about factor VII-activating protease (FSAP), which is activated by substances released from damaged cells such as histones and nucleosomes. Therefore, we have measured FSAP activation in trauma patients and have identified novel FSAP substrates in human plasma. Mass spectrometry-based methods were used to identify FSAP binding proteins in plasma. Anaphylatoxin generation was measured by ELISA, Western blotting, protein sequencing, and chemotaxis assays. Plasma samples from trauma patients were analyzed for FSAP Ag and activity, nucleosomes, C5a, and C3a. Among others, we found complement components C3 and C5 in FSAP coimmunoprecipitates. C3 and C5 were cleaved by FSAP in a dose- and time-dependent manner generating functional C3a and C5a anaphylatoxins. Activation of endogenous FSAP in plasma led to increased C5a generation, but this was not the case in plasma of a homozygous carrier of Marburg I single nucleotide polymorphism with lower FSAP activity. In multiple trauma patients there was a large increase in circulating FSAP activity and nucleosomes immediately after the injury. A high correlation between FSAP activity and C5a was found. These data suggest that activation of FSAP by tissue injury triggers anaphylatoxin generation and thereby modulates the posttraumatic inflammatory response in vivo. A strong link between C5a, nucleosomes, and FSAP activity indicates that this new principle might be important in the regulation of inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22308306     DOI: 10.4049/jimmunol.1103029

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury.

Authors:  Markus Bosmann; Jamison J Grailer; Robert Ruemmler; Norman F Russkamp; Firas S Zetoune; J Vidya Sarma; Theodore J Standiford; Peter A Ward
Journal:  FASEB J       Date:  2013-08-27       Impact factor: 5.191

2.  Role of extracellular histones in the cardiomyopathy of sepsis.

Authors:  Miriam Kalbitz; Jamison J Grailer; Fatemeh Fattahi; Lawrence Jajou; Todd J Herron; Katherine F Campbell; Firas S Zetoune; Markus Bosmann; J Vidya Sarma; Markus Huber-Lang; Florian Gebhard; Randall Loaiza; Hector H Valdivia; José Jalife; Mark W Russell; Peter A Ward
Journal:  FASEB J       Date:  2015-02-13       Impact factor: 5.191

3.  DNA and factor VII-activating protease protect against the cytotoxicity of histones.

Authors:  Gerben Marsman; Helen von Richthofen; Ingrid Bulder; Florea Lupu; Jan Hazelzet; Brenda M Luken; Sacha Zeerleder
Journal:  Blood Adv       Date:  2017-11-30

Review 4.  Complement and the Regulation of T Cell Responses.

Authors:  Erin E West; Martin Kolev; Claudia Kemper
Journal:  Annu Rev Immunol       Date:  2018-04-26       Impact factor: 28.527

Review 5.  Immunopathophysiology of trauma-related acute kidney injury.

Authors:  David A C Messerer; Rebecca Halbgebauer; Bo Nilsson; Hermann Pavenstädt; Peter Radermacher; Markus Huber-Lang
Journal:  Nat Rev Nephrol       Date:  2020-09-21       Impact factor: 28.314

6.  Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study.

Authors:  Mariana S Parahuleva; Sandip Kanse; Hans Hölschermann; Kirila Zheleva; Daniel Zandt; Michael Worsch; Behnoush Parviz; Norbert Güttler; Harald Tillmanns; Andreas Böning; Ali Erdogan
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

Review 7.  The "ins and outs" of complement-driven immune responses.

Authors:  Simon Freeley; Claudia Kemper; Gaëlle Le Friec
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

8.  New insights for C5a and C5a receptors in sepsis.

Authors:  Chunguang Yan; Hongwei Gao
Journal:  Front Immunol       Date:  2012-12-10       Impact factor: 7.561

Review 9.  Complement, thrombotic microangiopathy and disseminated intravascular coagulation.

Authors:  Shinichiro Kurosawa; Deborah J Stearns-Kurosawa
Journal:  J Intensive Care       Date:  2014-12-31

Review 10.  Complement--tapping into new sites and effector systems.

Authors:  Martin Kolev; Gaelle Le Friec; Claudia Kemper
Journal:  Nat Rev Immunol       Date:  2014-11-14       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.